Replies to post #24973 on CSMG Technologies, Inc (fka CTGI)

[sojourner]

bbhuey: Good question. FDA policy disallows official FDA publication of pending 510(k) applications. Not only that, only SE approvals are published; NSEs (i.e., disapprovals) are not revealed. However, it's likely CSMG would have notified shareholders of additional FDA filing(s) as happened pursuant to LTC's first 510(k).